In December 2025, J.P. Morgan upgraded Recursion Pharmaceuticals after REC-4881 showed rapid, durable polyp burden reductions and a favorable safety profile in familial adenomatous polyposis patients, ...
Carrillo’s promotion reflects Menlo Ventures’ commitment to strengthening its leadership bench and supporting the firm’s long ...
His job is to reimagine the future of drugmaking using that similarly trendy branch of computer science, artificial ...
Fruchter, G. (2026) Opportunism in Supply Chain Recommendations: A Dynamic Optimization Approach. Modern Economy, 17, 26-38.